Apollo Hospitals Enterprise Ltd. Q1 FY2027 results: revenue ₹7,044 crore, up 20.6% on the year
Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) reported consolidated revenue from operations of ₹7,044 crore for Q1 FY2027, the quarter ended 30 June 2026, up 20.6% on the same quarter a year earlier. Profit after tax was ₹610 crore, up 38.4% on the year, and earnings per share ₹40.39. The figures are the company's own, from the un-audited results it filed with NSE on 12 August 2026.
The quarter, against the one before and a year earlier
| Line | Q1 FY2027 | Q4 FY2026 | Q1 FY2026 | Change on the year |
|---|---|---|---|---|
| Revenue from operations | 7,044 | 6,606 | 5,842 | +20.6% |
| Other income | 49 | 44 | 40 | +21.4% |
| Total income | 7,092 | 6,649 | 5,882 | +20.6% |
| Cost of materials consumed | 829 | 777 | 740 | +12.0% |
| Purchases of stock-in-trade | 2,768 | 2,613 | 2,316 | +19.5% |
| Changes in inventories | 0 | 12 | -8 | n/a |
| Employee benefit expense | 796 | 772 | 713 | +11.7% |
| Finance costs | 120 | 119 | 108 | +11.2% |
| Depreciation, depletion and amortisation | 235 | 224 | 215 | +9.5% |
| Other expenses | 1,558 | 1,420 | 1,230 | +26.7% |
| Total expenses | 6,307 | 5,938 | 5,313 | +18.7% |
| Profit before exceptional items and tax | 785 | 711 | 569 | +38.0% |
| Exceptional items | 0 | 0 | 0 | n/a |
| Profit before tax | 785 | 711 | 569 | +38.0% |
| Current tax | 210 | 196 | 125 | +68.5% |
| Deferred tax | -22 | -26 | 17 | n/a |
| Total tax | 188 | 170 | 142 | +33.0% |
| Profit after tax | 610 | 551 | 441 | +38.4% |
| Attributable to owners of the parent | 581 | 529 | 433 | +34.2% |
| Other comprehensive income | 4 | -4 | 6 | -33.9% |
| Total comprehensive income | 614 | 547 | 447 | +37.5% |
| EPS, basic | ₹40.39 | ₹36.82 | ₹30.10 | +34.2% |
| EPS, diluted | ₹40.37 | ₹36.76 | ₹30.10 | +34.1% |
₹ crore except per share.
Segments, Q1 FY2027
| Segment | Revenue ₹ crore | Share of segment revenue | Result ₹ crore | Result over revenue |
|---|---|---|---|---|
| a) Healthcare services | 3,620 | 51.0% | 686 | 19.0% |
| b) Retail health and diagnostics | 500 | 7.0% | 23 | 4.5% |
| c) Digital health and pharmacy distribution | 2,977 | 42.0% | 152 | 5.1% |
| d) Others | 0 | n/a | -4 | n/a |
Segment revenue and segment result as the company filed them, before inter-segment eliminations; share and result over revenue are arithmetic on those.
Quarterly results, the last 12 quarters
| Q2 FY2024 | Q3 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | Q4 FY2026 | Q1 FY2027 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,847 | 4,851 | 4,944 | 5,086 | 5,589 | 5,527 | 5,592 | 5,842 | 6,304 | 6,477 | 6,606 | 7,044 |
| Expenses | 4,494 | 4,516 | 4,612 | 4,704 | 5,076 | 5,060 | 5,148 | 5,313 | 5,690 | 5,844 | 5,938 | 6,307 |
| Operating profit | 627 | 614 | 640 | 675 | 816 | 761 | 770 | 852 | 941 | 965 | 1,011 | 1,092 |
| OPM % | 13% | 13% | 13% | 13% | 15% | 14% | 14% | 15% | 15% | 15% | 15% | 16% |
| Other income | 22 | 28 | 28 | 37 | 38 | 64 | 61 | 40 | 55 | 53 | 44 | 49 |
| Interest | 111 | 113 | 119 | 116 | 118 | 110 | 115 | 108 | 110 | 113 | 119 | 120 |
| Depreciation | 163 | 167 | 190 | 177 | 184 | 185 | 211 | 215 | 218 | 219 | 224 | 235 |
| Exceptional items | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -19 | 0 | 0 |
| Profit before tax | 377 | 362 | 360 | 418 | 552 | 531 | 505 | 569 | 668 | 667 | 711 | 785 |
| Tax % | 35% | 30% | 31% | 27% | 29% | 30% | 20% | 25% | 27% | 25% | 24% | 24% |
| Net profit | 249 | 254 | 258 | 316 | 396 | 379 | 414 | 441 | 494 | 516 | 551 | 610 |
| EPS in ₹ | ₹16.20 | ₹17.06 | ₹17.65 | ₹21.23 | ₹26.34 | ₹25.89 | ₹27.10 | ₹30.10 | ₹33.19 | ₹34.94 | ₹36.82 | ₹40.39 |
| Filing | NSE | NSE | NSE | NSE | NSE | NSE | Filing | Filing | Filing | Filing | Filing | Filing |
₹ crore except per share, consolidated, as filed with the exchange. Operating profit is sales less the expenses other than interest and depreciation, OPM is that over sales, and tax % is tax over profit before tax: arithmetic on the filed lines; everything else is as filed. Quarters before December 2024 are from the exchange's earlier results feed, which carries the filed lines without the filing itself; the column links to the exchange's page for the company.
Source
Un-audited consolidated results for the quarter ended 30 June 2026, filed with NSE on 12 August 2026: the result statement. All of Apollo Hospitals Enterprise Ltd.'s results: NSE company page.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.